Ret Proto-Oncogene anticorps
-
- Antigène Voir toutes Ret Proto-Oncogene (RET) Anticorps
- Ret Proto-Oncogene (RET)
-
Reactivité
- Humain
-
Hôte
-
Poulet
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Ret Proto-Oncogene est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Specificité
- The RET proto-oncogeneis a receptor tyrosine kinase for members of the glial cell line-derivedneurotrophic factor family of extracellular signalling molecules
- Attributs du produit
- Mono- and polyclonal antibodies to human growth factors and neural growth factor receptors.
- Purification
- RET affinity purified
- Isotype
- IgY
- Top Product
- Discover our top product RET Anticorps primaire
-
-
- Indications d'application
- Westernimmunoblotting, recommended dilution 1:5 000 to 1:10 000, ELISA: 1:80 000 to 1:120000, IF 1:250 to 1:500. Polyclonal antibody working titer has to be established practically for each particularantigen and assay format
- Commentaires
-
Synonym: Proto-oncogene tyrosine-protein kinase receptorRet, Cadherin family member 12, Proto-oncogene c-Ret
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/ml
- Buffer
- Concentrated ammonium sulphate in PBS pH 7.4
- Conseil sur la manipulation
- As product is (NH4)2SO4 precipitate, mix well by pipetting or vortexing prior use
- Stock
- 4 °C
- Stockage commentaire
- This product is shipped in non-frozen liquid form in ambient conditions
-
- Antigène
- Ret Proto-Oncogene (RET)
- Autre désignation
- RET (RET Produits)
- Sujet
- Recombinant His-tagged extracellular fragment of humanRET protein produced using CHO-based cell line. The extracellular fragment of hRET was expressed andsecreted to the cell culture supernatant. Protein was purified by Ni-affinitychromatography following gel-filtration from cell culture supernatant
- UniProt
- P07949
- Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-